Oncothermia

OTHER3 trials

Sponsors

Seoul National University Hospital

Conditions

Cancer, PancreasEpithelial Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma

Phase 1

Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients

CompletedNCT02150135

Seoul National University HospitalCancer, Pancreas

Start: 2014-06-30End: 2015-11-30Updated: 2016-09-07

A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer

CompletedNCT02344095

Seoul National University HospitalEpithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma

Start: 2014-12-31End: 2017-10-31Updated: 2024-07-12

Phase 2

Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients

Seoul National University HospitalCancer, Pancreas

Start: 2016-08-31End: 2019-07-31Target: 100Updated: 2017-10-31

Related Papers

Modulated electro‑hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial

Experimental and Therapeutic Medicine2021-05-213 citations

A phase I trial evaluating the safety and efficacy of weekly paclitaxel or cisplatin with electro-hyperthermia in patients with recurrent or persistent epithelial ovarian, fallopian tubal or primary peritoneal carcinoma (KGOG 3030).

Journal of Clinical Oncology2019-05-20